Leadership
Proven industry veterans with deep oncology expertise.
For over a decade, the Coherus team has successfully launched multiple drugs. Our drug discovery, development and commercialization experience combined with our relentless commitment to improving patient care will continue to drive our success in immuno-oncology.
Dennis M. Lanfear
President & Chief Executive Officer
Rosh Dias, M.D., M.R.C.P.
Chief Medical Officer
Richard L. Hameister
Chief Technical Officer
Theresa LaVallee, Ph.D.
Chief Development Officer
Bryan McMichael
Chief Financial Officer
Rebecca Sunshine
Chief Human Resources Officer
Andy Rittenberg
Executive Vice President, General Counsel
Scott Saywell
Executive Vice President, Corporate Development
Let’s do some great work together to bring next-generation therapies to patients.
